PARIS
France
54
2022-08-11
46
2025-01-21
These are the the leading inventors for applications assigned to INSERM:
INSERM based in PARIS, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Biomarkers of fast progression of chronic kidney disease
#2 | 2021-08-05 ✅ Patent 11,364,271 granted on 2022-06-21Methods of treating respiratory infections
#3 | 2021-07-08 ✅ Patent 11,351,156 granted on 2022-06-07Combination treatment of pancreatic cancer
#4 | 2020-12-03 ✅ Patent 11,904,004 granted on 2024-02-20Anti-CD277 antibodies
#5 | 2020-10-08 ✅ Patent 11,525,165 granted on 2022-12-13Method of selection of an IRE1-inhibitor therapy for patient suffering from cancer
#6 | 2020-10-08 ✅ Patent 11,510,936 granted on 2022-11-29Methods and pharmaceutical composition for the treatment of neurodegenerative disease
#7 | 2020-09-10 ✅ Patent 11,572,409 granted on 2023-02-07Antibodies having specificity for BTN2 and uses thereof
#8 | 2020-04-09 ✅ Patent 11,389,434 granted on 2022-07-19Methods and pharmaceutical compositions for the treatment of mast cell diseases
#9 | 2019-08-08 ✅ Patent 10,918,647 granted on 2021-02-16Selective bromodomain inhibition of fungal Bdf1
#10 | 2019-07-11 ✅ Patent 11,376,269 granted on 2022-07-05Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (AML)
#11 | 2019-01-31 ✅ Patent 11,667,913 granted on 2023-06-06Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
#12 | 2019-01-31 ✅ Patent 11,221,341 granted on 2022-01-11Process for in vitro diagnosis of hepatic disorders
#13 | 2018-11-15 ✅ Patent 11,448,656 granted on 2022-09-20Compositions useful in the diagnostic of latently infected
#14 | 2018-09-20 ✅ Patent 11,231,418 granted on 2022-01-25Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (CLL) and/or of systemic lupus erythematosus (SLE) using membrane STIM 1
#15 | 2018-07-19 ✅ Patent 10,619,137 granted on 2020-04-14Method for rapid generation of an attenuated RNA virus
#16 | 2018-04-26 ✅ Patent 11,643,639 granted on 2023-05-09Skin reconstruction method
#17 | 2018-01-18 ✅ Patent 10,143,060 granted on 2018-11-27Lighting equipment with optimum stimulation of non-visual functions
#18 | 2017-12-21 ✅ Patent 10,144,917 granted on 2018-12-04Method for preparing a vaccine antigen, resulting vaccine antigen and uses
#19 | 2017-10-19 ✅ Patent 10,106,801 granted on 2018-10-23Auto-inducible expression system
#20 | 2017-09-28 ✅ Patent 10,955,535 granted on 2021-03-23Acoustic imaging method and device for detecting linearly combined reverberated waves via decoding matrices
#21 | 2017-08-03 ✅ Patent 10,172,961 granted on 2019-01-08Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them
#22 | 2017-07-27 ✅ Patent 9,932,309 granted on 2018-04-032-oxo-3,4-dihydropyridine-5-carboxylates and their use
#23 | 2017-05-11 ✅ Patent 11,278,543 granted on 2022-03-22Inhibitors of the PP1/GADD34 complex for the treatment of a condition requiring an immunosuppressive activity
#24 | 2015-11-12USE OF ACETYLSALICYLIC ACID TO PREVENT AND/OR TREAT DIABETIC WOUNDS
#25 | 2015-07-30 ✅ Patent 9,528,086 granted on 2016-12-27Recombinant strains
#26 | 2015-02-26 ✅ Patent 10,188,695 granted on 2019-01-29Calcineurin inhibitors for use in the treatment of lesional vestibular disorders
#27 | 2014-10-02 ✅ Patent 10,150,989 granted on 2018-12-11Fibrosis susceptibility IL22RA2 gene and uses thereof
#28 | 2014-09-25DDR1 ANTAGONIST OR AN INHIBITOR OF DDR1 GENE EXPRESSION FOR USE IN THE PREVENTION OR TREATMENT OF CRESCENTIC GLOMERULONEPHRITIS
#29 | 2014-06-12 ✅ Patent 9,446,109 granted on 2016-09-20Glycoconjugates and their use as potential vaccines against infection by
#30 | 2013-03-07TREATMENT OF NEUROLOGICAL OR NEURODEGENERATIVE DISORDERS
#31 | 2012-12-27 ✅ Patent 8,604,060 granted on 2013-12-10Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases
#32 | 2012-11-29 ✅ Patent 8,648,044 granted on 2014-02-11FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#33 | 2012-08-30 ✅ Patent 9,115,190 granted on 2015-08-25Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
#34 | 2011-12-22 ✅ Patent 8,652,459 granted on 2014-02-18Splitting GP41
#35 | 2010-12-23 ✅ Patent 8,524,652 granted on 2013-09-03Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest
#36 | 2010-11-18 ✅ Patent 9,867,971 granted on 2018-01-16Device for administering cells and cell-therapy methods using said device
#37 | 2010-10-14 ✅ Patent 8,586,822 granted on 2013-11-19Methods for producing a non human model for aortic aneurysm
#38 | 2010-07-08 ✅ Patent 8,858,931 granted on 2014-10-14Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
#39 | 2009-12-24Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2
#40 | 2009-07-23 ✅ Patent 8,007,792 granted on 2011-08-30Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
#41 | 2009-07-09 ✅ Patent 8,003,773 granted on 2011-08-23Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
#42 | 2009-05-26 ✅ Patent 7,537,932 granted on 2009-05-26Antibodies that bind purified mammalian FLT3 ligands
#43 | 2009-05-19 ✅ Patent 7,534,867 granted on 2009-05-19Purified mammalian Flt3 ligands; agonists; antagonists
#44 | 2009-01-08 ✅ Patent 8,153,781 granted on 2012-04-10Dendrimer conjugates of agonists and antagonists of the GPCR superfamily
#45 | 2008-10-30Oatp-C Gene C463a Polymorphism Underlies Variable Response to Statin Therapy
#46 | 2008-05-01BIPOTENTIAL LIVER CELL LINES FROM WILD-TYPE MAMMALIAN LIVER TISSUE
#47 | 2007-11-15 ✅ Patent 7,629,439 granted on 2009-12-08Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy
#48 | 2007-10-25Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
#49 | 2007-05-01 ✅ Patent 7,211,399 granted on 2007-05-01Method for detecting leptin receptor ligands
#50 | 2007-03-06 ✅ Patent 7,186,558 granted on 2007-03-06Keratinocytes obtained from embryonic stem cells of mammals
#51 | 2007-02-01 ✅ Patent 7,524,650 granted on 2009-04-28Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
#52 | 2007-01-18 ✅ Patent 7,589,110 granted on 2009-09-15Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
#53 | 2005-11-24 ✅ Patent 7,479,497 granted on 2009-01-20Use of quinoline derivatives with anti-integrase effect and applications thereof
#54 | 2005-04-07Bipotential liver cell lines from wild-type mammalian liver tissue
Also check out INSERM's (Paris, France) applicant profile with 22 patent applications submitted.
12691 ⎘